Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268

1.

The Water Diffusion of Brain Following Hypoglycemia in Rats - A Study with Diffusion Weighted Imaging and Neuropathologic Analysis.

Tong F, Zou Y, Liang Y, Lei H, Lopsong T, Liu Y, Le Grange JM, He G, Zhou Y.

Neuroscience. 2019 Jun 15;409:58-68. doi: 10.1016/j.neuroscience.2019.04.036. Epub 2019 Apr 26.

PMID:
31034973
2.

Sudden death from an epileptic seizure due to capillary telangiectasias in the hippocampus.

Liu Y, Liang Y, Tong F, Huang W, Tinzing L, Le Grange JM, Wang F, Zhou Y.

Forensic Sci Med Pathol. 2019 Jun;15(2):243-248. doi: 10.1007/s12024-018-0075-7. Epub 2019 Jan 16. Review.

PMID:
30649694
3.

Ancient Retrovirus Targeted by Engineered T Cells in Melanoma--Letter.

Grange JM, Krone B.

Clin Cancer Res. 2015 Oct 1;21(19):4494. doi: 10.1158/1078-0432.CCR-15-1548. No abstract available.

4.

Vaccination, infection, and the risk for multiple sclerosis.

Krone B, Grange JM.

JAMA Neurol. 2015 Apr;72(4):480. doi: 10.1001/jamaneurol.2014.4708. No abstract available.

PMID:
25867731
5.

The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies.

Krone B, Kölmel KF, Grange JM.

BMC Cancer. 2014 Aug 16;14:595. doi: 10.1186/1471-2407-14-595. Review.

7.

Childhood infectious diseases and risk of leukaemia in an adult population.

Krone B, Kölmel KF, Grange JM.

Int J Cancer. 2014 Jan 15;134(2):495-6. doi: 10.1002/ijc.28370. Epub 2013 Aug 1. No abstract available.

8.

Paradigms in multiple sclerosis: time for a change, time for a unifying concept.

Krone B, Grange JM.

Inflammopharmacology. 2011 Aug;19(4):187-95. doi: 10.1007/s10787-011-0084-6. Epub 2011 May 6.

9.

Tuberculosis and tubulointerstitial nephritis: an intriguing puzzle.

Eastwood JB, Corbishley CM, Grange JM.

Kidney Int. 2011 Mar;79(6):579-581. doi: 10.1038/ki.2010.495.

10.

Immune protection against tuberculosis--when is immunotherapy preferable to vaccination?

Grange JM, Brunet LR, Rieder HL.

Tuberculosis (Edinb). 2011 Mar;91(2):179-85. doi: 10.1016/j.tube.2010.12.004. Epub 2011 Jan 12. Review.

PMID:
21233019
11.

Multiple sclerosis: are protective immune mechanisms compromised by a complex infectious background?

Krone B, Grange JM.

Autoimmune Dis. 2010 Dec 20;2011:708750. doi: 10.4061/2011/708750.

12.
13.

Melanoma, Darwinian medicine and the inner world.

Krone B, Grange JM.

J Cancer Res Clin Oncol. 2010 Dec;136(12):1787-94. doi: 10.1007/s00432-010-0949-x. Epub 2010 Sep 18. Review.

14.

Infection, inflammation and cancer.

Grange JM, Krone B, Mastrangelo G.

Int J Cancer. 2011 May 1;128(9):2240-1. doi: 10.1002/ijc.25533. No abstract available.

15.

Prophylactic intervention for childhood leukaemia.

Grange JM, Krone B.

Int J Epidemiol. 2011 Feb;40(1):258-9. doi: 10.1093/ije/dyq076. Epub 2010 Apr 29. No abstract available.

PMID:
20430829
16.

Can prior vaccinations against certain infections confer protection against developing melanoma?

Grange JM, Krone B, Kölmel KF, Mastrangelo G.

Med J Aust. 2009 Nov 2;191(9):478-9.

PMID:
19883339
17.

Chronic inflammation as a manifestation of defects in immunoregulatory networks: implications for novel therapies based on microbial products.

Bottasso O, Docena G, Stanford JL, Grange JM.

Inflammopharmacology. 2009 Aug;17(4):193-203. doi: 10.1007/s10787-009-0008-x. Epub 2009 Jul 14. Review.

PMID:
19597940
18.

Immunotherapy for malignant melanoma--tracing Ariadne's thread through the labyrinth.

Grange JM, Krone B, Stanford JL.

Eur J Cancer. 2009 Sep;45(13):2266-73. doi: 10.1016/j.ejca.2009.05.002. Epub 2009 Jun 3. Review.

PMID:
19497734
19.

Is the risk of multiple sclerosis related to the 'biography' of the immune system?

Krone B, Oeffner F, Grange JM.

J Neurol. 2009 Jul;256(7):1052-60. doi: 10.1007/s00415-009-5068-8. Epub 2009 Mar 1. Review.

20.

The biosocial dynamics of tuberculosis.

Grange JM, Kapata N, Chanda D, Mwaba P, Zumla A.

Trop Med Int Health. 2009 Feb;14(2):124-30. doi: 10.1111/j.1365-3156.2008.02205.x. Epub 2009 Jan 15.

21.

Does yellow fever 17D vaccine protect against melanoma?

Mastrangelo G, Krone B, Fadda E, Buja A, Grange JM, Rausa G, de Vries E, Koelmel KF.

Vaccine. 2009 Jan 22;27(4):588-91. doi: 10.1016/j.vaccine.2008.10.076. Epub 2008 Nov 14.

PMID:
19010368
22.

The use of mycobacterial adjuvant-based agents for immunotherapy of cancer.

Grange JM, Bottasso O, Stanford CA, Stanford JL.

Vaccine. 2008 Sep 15;26(39):4984-90. doi: 10.1016/j.vaccine.2008.06.092. Epub 2008 Jul 14. Review.

PMID:
18625281
23.

Pathogen-associated molecular pattern in cancer immunotherapy.

Hobohm U, Stanford JL, Grange JM.

Crit Rev Immunol. 2008;28(2):95-107. Review.

PMID:
18540826
24.

Common infectious agents in multiple sclerosis: a case-control study in children.

Krone B, Pohl D, Rostasy K, Kahler E, Brunner E, Oeffner F, Grange JM, Gärtner J, Hanefeld F.

Mult Scler. 2008 Jan;14(1):136-9. Epub 2007 Oct 17.

PMID:
17942525
25.

Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung.

Stanford JL, Stanford CA, O'Brien ME, Grange JM.

Eur J Cancer. 2008 Jan;44(2):224-7. Epub 2007 Oct 24.

PMID:
17928219
26.

The British Royal Commission on Tuberculosis.

Grange JM.

J R Soc Med. 2007 Jan;100(1):7-8. No abstract available.

27.

Miss, Mister, Doctor. Preferred titles.

Grange JM.

J R Soc Med. 2006 Jul;99(7):335. No abstract available.

28.

Treatment of tuberculosis: present status and future prospects.

Onyebujoh P, Zumla A, Ribeiro I, Rustomjee R, Mwaba P, Gomes M, Grange JM.

Bull World Health Organ. 2005 Nov;83(11):857-65. Epub 2005 Nov 10. Review.

29.

Protection in the (farm) dust.

Mastrangelo G, Grange JM, Lange JH.

Int J Tuberc Lung Dis. 2005 Oct;9(10):1178. No abstract available.

PMID:
16229233
30.

Leprosy of the past and today.

Grange JM, Lethaby JI.

Semin Respir Crit Care Med. 2004 Jun;25(3):271-81.

PMID:
16088469
31.

Elevated lung cancer risk shortly after smoking cessation: is it due to a reduction of endotoxin exposure?

Lange JH, Mastrangelo G, Fadda E, Priolo G, Montemurro D, Buja A, Grange JM.

Med Hypotheses. 2005;65(3):534-41.

PMID:
15913904
32.

Lung cancer risk: effect of dairy farming and the consequence of removing that occupational exposure.

Mastrangelo G, Grange JM, Fadda E, Fedeli U, Buja A, Lange JH.

Am J Epidemiol. 2005 Jun 1;161(11):1037-46.

PMID:
15901624
33.

Bovine tuberculosis in Africa.

Grange JM.

Int J Tuberc Lung Dis. 2005 Apr;9(4):470. No abstract available.

PMID:
15830758
34.

Human endogenous retroviruses in health and disease.

Grange JM, Krone B, Kölmel K.

J R Soc Med. 2005 Mar;98(3):134. No abstract available.

35.

Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients.

Kölmel KF, Grange JM, Krone B, Mastrangelo G, Rossi CR, Henz BM, Seebacher C, Botev IN, Niin M, Lambert D, Shafir R, Kokoschka EM, Kleeberg UR, Gefeller O, Pfahlberg A.

Eur J Cancer. 2005 Jan;41(1):118-25.

PMID:
15617996
37.

Infection, vaccination and protection against melanoma - a ray of hope for novel preventive and therapeutic strategies?

Grange JM, Doré JF, Coebergh JW.

Eur J Cancer. 2005 Jan;41(1):12-4. No abstract available.

PMID:
15617986
38.

Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study.

Krone B, Kölmel KF, Grange JM, Mastrangelo G, Henz BM, Botev IN, Niin M, Seebacher C, Lambert D, Shafir R, Kokoschka EM, Kleeberg UR, Gefeller O, Pfahlberg A.

Eur J Cancer. 2003 Nov;39(16):2372-8.

PMID:
14556930
39.

Vaccination strategies to reduce the risk of leukaemia and melanoma.

Grange JM, Stanford JL, Stanford CA, Kölmel KF.

J R Soc Med. 2003 Aug;96(8):389-92. Review. No abstract available.

40.

DOTS--keep on smiling.

Grange JM.

Int J Tuberc Lung Dis. 2003 Jul;7(7):708. No abstract available.

PMID:
12870696
41.

Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study.

Pfahlberg A, Kölmel KF, Grange JM, Mastrangelo G, Krone B, Botev IN, Niin M, Seebacher C, Lambert D, Shafir R, Schneider D, Kokoschka EM, Kleeberg UR, Uter W, Gefeller O.

J Invest Dermatol. 2002 Sep;119(3):570-5.

42.

The global emergency of tuberculosis: what is the cause?

Grange JM, Zumla A.

J R Soc Promot Health. 2002 Jun;122(2):78-81.

PMID:
12134771
43.

Campbell De Morgan's 'Observations on cancer', and their relevance today.

Grange JM, Stanford JL, Stanford CA.

J R Soc Med. 2002 Jun;95(6):296-9. No abstract available.

44.

Multidrug-resistant tuberculosis--can the tide be turned?

Zumla A, Grange JM.

Lancet Infect Dis. 2001 Oct;1(3):199-202. Review.

PMID:
11871496
45.

Would you know one if you met one?

Grange JM.

Int J Tuberc Lung Dis. 2001 Dec;5(12):1162-3. No abstract available.

PMID:
11769777
46.

Environmental echoes.

Stanford JL, Stanford CA, Grange JM.

Sci Prog. 2001;84(Pt 2):105-24.

PMID:
11525013
47.

Factors affecting susceptibility and resistance to tuberculosis.

Davies PD, Grange JM.

Thorax. 2001 Sep;56 Suppl 2:ii23-9. Review. No abstract available.

48.

Mycobacterium bovis infection in human beings.

Grange JM.

Tuberculosis (Edinb). 2001;81(1-2):71-7. Review.

PMID:
11463226
49.
50.

Tuberculosis and the kidney.

Eastwood JB, Corbishley CM, Grange JM.

J Am Soc Nephrol. 2001 Jun;12(6):1307-14. Review. No abstract available.

Supplemental Content

Loading ...
Support Center